EU links Johnon & Johnson coronavirus shot to rare blood clots, says odds favor use
The European Unionâs drug regulatory agency says the vaccineâs benefits still outweigh the risks of contracting the coronavirus.
Â
Â
In this April 13 photo, a box of Johnson & Johnson vaccines are shown by pharmacist Zsolt Szenasi at a warehouse of Hungaropharma, a Hungarian pharmaceutical wholesale company, in Budapest, Hungary. Experts at the European Medicines Agency are preparing to present the conclusions of their investigation later on Tuesday, April 20, 2021, into possible links between the Johnson & Johnson coronavirus vaccine and very rare cases of unusual clotting disorders detected in the U.S. [ SZILARD KOSZTICSAK | AP ]